Nuvation Bio
Nuvation Bio is a global oncology company focused on tackling some of the toughest challenges in cancer treatment.
238 employees · est. 2018 · New York, United States
Prelude Therapeutics
Precision Oncology, Redefined.
126 employees · est. 2016 · Wilmington, United States
Prelude Therapeutics is the older company (2018 vs 2016); Nuvation Bio is the larger of the two.
Side-by-Side Comparison
| Metric | Nuvation Bio | Prelude Therapeutics |
|---|---|---|
| Founded | ||
| Founded | 2018 | 2016 older |
| Headquarters | ||
| Headquarters | New York, United States | Wilmington, United States |
| Employees | ||
| Employees | 238 larger | 126 |
| Industry | ||
| Industry | Biotechnology, Health Care, Pharmaceutical | Biopharma, Biotechnology, Health and Wellness |
| Funding Stage | ||
| Funding Stage | Post Ipo Equity | Post Ipo Equity |
| Total Funding | ||
| Total Funding | $777.00M | $147.00M |
| Funding Rounds | ||
| Funding Rounds | 2 | 4 |
| Services | ||
| Services | Not tracked yet | Development of precision oncology medicines, Innovative cancer drug discovery, Targeted protein degradation technology, Pipeline of clinical and preclinical programs |
| Target Customers | ||
| Target Customers | Not tracked yet | Cancer Patients, Oncologists, Healthcare Providers, Pharmaceutical Partners |
| Taxonomy | ||
| Taxonomy | Biopharmaceutical Company, Oncology, Cancer Treatment, Therapeutic Candidates, Proprietary Portfolio, Novel, Mechanistically Distinct, Difficult-to-treat Cancers, David Hung, Medivation Inc., Prostate Cancer Medicine, Biopharma Industry, New York, San Francisco | Precision Oncology, Clinical-stage, Cancer Therapeutics, Small Molecule Compounds, Targeted Cancer Pathways, SMARCA2 Degrader, CDK9 Inhibitor, CDK4/6 Inhibitor, Cancer Resistance Mechanisms, Oncology Drug Development, Orally Bioavailable Therapies, Novel Cancer Therapies, Healthcare Innovation, Cancer Research |
| Website | ||
| Website | nuvationbio.com | preludetx.com |
About Nuvation Bio
Nuvation Bio is a late-stage, global biopharmaceutical company founded in 2018, with headquarters in the United States. The company's mission, as reflected in its slogan "Nuvation Bio is focused on treating the most difficult-to-treat cancers, for which conventional therapies have failed," is to add...
About Prelude Therapeutics
Prelude Therapeutics, founded in 2016, is a United States-based clinical-stage precision oncology company redefining cancer treatment with a focus on developing innovative drug candidates that target critical cancer cell pathways. The company uniquely positions itself within the Biopharma, Biotechno...
We will tell you when either one moves
BounceWatch watches Nuvation Bio and Prelude Therapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Nuvation Bio and Prelude Therapeutics — by email.
Frequently Asked Questions
Compare Nuvation Bio with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at Nuvation Bio on 9 Jun 2026, and Prelude Therapeutics on 27 Nov 2025. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.